US 11850261
Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells
granted A61KA61K35/12A61P
Quick answer
US patent 11850261 (Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells) held by Astellas Institute for Regenerative Medicine expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Astellas Institute for Regenerative Medicine
- Grant date
- Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K35/12, A61P, A61P27/02